LFMD · LifeMD, Inc.
$4.15
-0.35 (-7.78%)
At close · Jul 17
Market Cap
$200.70M
Shares
48.36M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$4.15
Open$4.39
Day$4.09–4.39
52W$2.56–12.72
Avg vol 30d948K
Short int6.4M · 13.2% float · 5.7d
Short vol61%
Last earningsMay 6, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 6
Up next
Next earnings call
Aug 12, 2026
Est · unconfirmed
· in 3 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 6, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Sell
Momentum
Strong
Sentiment
Neutral
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 18.7 · elevated
Equity put/call 0.66
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−3%
below
Price vs 50-day avg
−9%
below
RSI (14)
40
neutral
MACD trend
Negative
52-week position
16%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−15%
trailing
6-month return
+16%
trailing
YTD return
+22%
this year
Relative strength
+8%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
8 of 102 funds reported for Jun 30 · net +103.3K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
13.23% of float · ▲ +9.0% MoM · 5.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
102 holders — mid 3-yr range
Squeeze score
73
high risk · 0–100
Fundamentals
Revenue growth
+50%
Y/Y
Gross margin
1334%
contracting
EPS growth
+142%
Y/Y
Free cash flow
$6.4M
Balance sheet
$35.0M
net cash
Quant / Vol
risk profile
Volatility
92%
annualized · 1-yr
Max drawdown
−79%
past year
ATR
7.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Equibles Research
All LFMD researchGuidance & track record
Latest guidance
· from the 8-K filed May 6, 2026
Revenue
· full year 2026
Initiated
$220M – $230M
prior FY $194.06M
midpoint +15.9% Y/Y
Adjusted EBITDA
· full year 2026
Initiated
$12M – $17M
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−3%
Neutral
Price vs 50-day avg
−9%
Bearish
RSI (14)
40
Neutral
MACD trend
Negative
Bearish
52-week position
16%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $5 › 200d $4 — 50d above 200d
Institutional flow
Accumulating
8 of 102 funds reported for Jun 30 · net +103.3K sh shares · +2 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
13.23% of float · ▲ +9.0% MoM · 5.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
102 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $3
Now $4 · 16%
52-wk high $13
vs 200-day avg -3%
vs 50-day avg -9%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| active telehealth subscribers | 365,000 | Q1 2026 | — |
| adjusted EBITDA loss non-GAAP | -$4.5M | Q1 2026 | — |
| net telehealth subscribers added | 42,000 | Q1 2026 | — |
| Weight Management program subscribers | 100,000 | Q1 2026 | — |
| active patients | 215K | Q1 call | — |
| active subscribers | 365K | Q1 call | — |
| covered lives | 112M | Q1 call | — |
| pharmacy prescriptions per month | 20K | Q1 call | — |
| subscribers | 365K | Q1 call | — |
| Adjusted EBITDA non-GAAP | $4,759K | Three Months Ended Dec. 31, 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Health Information Services — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
LFMD
this stock
LifeMD, Inc.
|
$200.70M | +21.7% | +126.1% | — | 13.2% |
|
VEEV
Veeva Systems Inc
|
$32.07B | -11.6% | +28.1% | 35.0 | 4.6% |
|
PMDIY
Pro Medicus Ltd./ADR
|
$15.41B | -10.9% | — | — | 0.0% |
|
BTSG
BrightSpring Health Services, Inc.
|
$13.67B | +88.3% | -0.4% | 50.4 | 6.6% |
|
TEM
Tempus AI, Inc.
|
$9.42B | -11.1% | +65.8% | — | 18.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| LFMD | -10.6% | -15.5% | +15.9% | +0.5% | +21.7% |
| SPY | -1.5% | +0.3% | +7.8% | -0.5% | +9.0% |
| vs SPY | -9.0% | -15.8% | +8.1% | +1.0% | +12.7% |